Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 151 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Boehringer, CAR T, CAR-T, Celgene, Kymriah, Merck KGaA, Novartis, Philippines, Sanofi, gilotrif, juno therapeutics, nestle, top ten

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …

News
old_man_bar

Another Alzheimer’s drug bites the dust in P3

January 12, 2018
Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and

News
hands-981400_960_720

New project examining FDA-approved drugs for Alzheimer’s, worries over research remains

January 10, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …

News
alzheimers_brain

Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals

October 31, 2017
Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia

LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …

News
8384110298_da510e0347_c

Research finds blood-thinners protect against dementia

October 25, 2017
Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …

News
brainss

Axovant shares capitulate after Alzheimer’s drug failure

September 26, 2017
Research and Development Alzheimer's, Axovant, biotech, drugs, pharma, pharmaceutical

Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …

News
alzheimers-749616_960_720

Alzheimer’s disease: Fighting back against a growing threat

September 11, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma

September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …

Feature
shutterstock_311949818

Stomach acid drugs do not increase Alzheimer’s risk, study confirms

August 7, 2017
Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

News
brainss

Enzyme able to untangle protein aggregates associated with Alzheimer’s

June 29, 2017
Research and Development Alzheimer's, Parkinson's

There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …

News
shutterstock_311949818

Immune system attacks the brain in Alzheimer’s, study suggests

June 22, 2017
Research and Development Alzheimer's

New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a …

News
cuba

Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s

May 16, 2017
Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia

The health care system in Cuba is widely held up to be a model of innovation; despite severe economic  sanctions …

News
800px-lab_mouse_mg_3154

New drug study successfully halts neurodegeneration in mice

April 20, 2017
Research and Development Alzheimer's, Parkinson's, trazodone

A team of scientists at Medical Research Council’s (MRC) Toxicology Unit in Leicester, UK have identified methods to prevent neurodegeneration …

News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017
Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …

News
merck_entrance

MSD’s Alzheimer’s drug failure undermines potential treatment pathway

February 15, 2017
Research and Development Alzheimer's, MSD, Merck

MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …

News

Two Phase 3 failures put nail in the coffin for Lundbeck Alzheimer’s drug

February 9, 2017
Research and Development, Sales and Marketing Alzheimer's, Lundbeck, idalopirdine

Danish pharma firm Lundbeck has announced the failure of two Phase 3 trials investigating its experimental Alzheimer’s treatment idalopirdine; the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025